PLN 16.78
(0.66%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 45.41 Million | -56.04 Million | 41.36 Million | 42.17 Million | 29.49 Million | -11.42 Million |
Net Income | 64.96 Million | 91.04 Million | 94.24 Million | 44.66 Million | 18.96 Million | 15.13 Million |
Depreciation & Amortization | 7.72 Million | 5.78 Million | 5.07 Million | 4.38 Million | 4.03 Million | 2.56 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -35.04 Million | -137.18 Million | -39.06 Million | -4.33 Million | 12.23 Million | -23.32 Million |
Other non-cash items | 7.75 Million | -15.69 Million | -18.88 Million | -2.54 Million | -5.73 Million | -5.79 Million |
Investing Cash Flow | -11.71 Million | -11.07 Million | -15.02 Million | -4.75 Million | -3.64 Million | -3.13 Million |
Investments in PPE | -17.68 Million | -11.5 Million | -13.98 Million | -4.41 Million | -2.87 Million | -3.38 Million |
Acquisitions | -2.47 Million | -1.19 Million | -1.18 Million | -594 Thousand | -1.04 Million | 111 Thousand |
Investment purchases | -1.39 Million | - | - | - | - | - |
Sales/Maturities of investments | 1.29 Million | - | - | - | - | - |
Other Investing Activities | 8.53 Million | 1.63 Million | 146 Thousand | 255 Thousand | 275 Thousand | 137 Thousand |
Financing Cash Flow | -17.74 Million | 8.55 Million | 10.89 Million | -2.04 Million | -5.65 Million | 26.73 Million |
Debt repayment | -2.27 Million | -1.19 Million | -2.88 Million | -7.67 Million | -598 Thousand | -2.73 Million |
Dividends payments | -24.97 Million | -16.57 Million | -22.19 Million | -9.68 Million | -6.08 Million | -6.1 Million |
Common Stock Repurchased | - | -996 Thousand | - | -36 Thousand | -162 Thousand | - |
Common Stock Issuance | - | 996 Thousand | - | - | - | - |
Other Financing Activities | -130 Thousand | 26.31 Million | 35.97 Million | 7.67 Million | 598 Thousand | 32.83 Million |
Accounts receivables | -36.26 Million | 22.32 Million | -56.77 Million | -84.13 Million | -35.67 Million | 65.91 Million |
Accounts payables | 36.26 Million | -22.32 Million | 56.77 Million | 84.13 Million | 35.67 Million | - |
Inventory | 81.06 Million | -192.98 Million | -46.4 Million | -12.92 Million | -86.38 Million | -33.51 Million |
Other working capital | -116.1 Million | 55.79 Million | 7.33 Million | 8.59 Million | 98.61 Million | 10.18 Million |
Cash at beginning of period | 92.35 Million | 150.92 Million | 113.68 Million | 78.3 Million | 58.1 Million | 45.93 Million |
Cash at end of period | 108.3 Million | 92.35 Million | 150.92 Million | 113.68 Million | 78.3 Million | 58.1 Million |
Capital Expenditure | -17.68 Million | -11.5 Million | -13.98 Million | -4.41 Million | -2.87 Million | -3.38 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 15.95 Million | -58.56 Million | 37.23 Million | 35.37 Million | 20.19 Million | 12.17 Million |
Free Cash Flow | 27.72 Million | -67.55 Million | 27.37 Million | 37.75 Million | 26.62 Million | -14.8 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 7.9 Million | 16.99 Million | 4.35 Million | 64.96 Million | 26.18 Million | 13.53 Million |
Depreciation & Amortization | 2.17 Million | 2.13 Million | 2.02 Million | 7.72 Million | 1.91 Million | 1.85 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -31.02 Million | -55.94 Million | 49.63 Million | -35.04 Million | -11.55 Million | 44.32 Million |
Other non-cash items | 3.75 Million | 3.63 Million | 26.64 Million | 7.75 Million | -13.22 Million | -275 Thousand |
Investing Cash Flow | -5.8 Million | -3.5 Million | -7.71 Million | -11.71 Million | 5.88 Million | -6.04 Million |
Investments in PPE | -3.67 Million | -3.82 Million | -4.38 Million | -17.68 Million | -1.91 Million | -7.8 Million |
Acquisitions | - | -22 Thousand | -2.41 Million | -2.47 Million | -380 Thousand | 1.18 Million |
Investment purchases | - | - | - | -1.39 Million | - | - |
Sales/Maturities of investments | - | - | - | 1.29 Million | - | - |
Other Investing Activities | -2.47 Million | -182 Thousand | -920 Thousand | 8.53 Million | 8.18 Million | 576 Thousand |
Financing Cash Flow | -44.26 Million | 12.67 Million | 5.59 Million | -17.74 Million | 3.29 Million | -31.91 Million |
Debt repayment | -27.62 Million | -12.65 Million | -206 Thousand | -2.27 Million | -1.45 Million | -395 Thousand |
Dividends payments | -16.64 Million | - | -11.1 Million | -24.97 Million | -13.87 Million | - |
Common Stock Repurchased | -21 Thousand | - | - | - | - | - |
Common Stock Issuance | 13 Thousand | 21 Thousand | - | - | - | - |
Other Financing Activities | -25.98 Million | -151 Thousand | 8.5 Million | -130 Thousand | 18.62 Million | -31.51 Million |
Accounts receivables | 70.08 Million | 4.86 Million | 6.99 Million | -36.26 Million | -54.15 Million | 9.81 Million |
Accounts payables | - | - | -6.99 Million | 36.26 Million | 54.15 Million | -9.81 Million |
Inventory | 28.66 Million | -56.66 Million | 65.3 Million | 81.06 Million | -3.07 Million | 6.63 Million |
Other working capital | -37.2 Million | 1.62 Million | -15.67 Million | -116.1 Million | -8.47 Million | 37.68 Million |
Cash at beginning of period | 75.96 Million | 108.3 Million | 27.75 Million | 92.35 Million | 15.25 Million | -6.22 Million |
Cash at end of period | 1.29 Million | 75.96 Million | 108.3 Million | 108.3 Million | 27.75 Million | 15.25 Million |
Capital Expenditure | -3.67 Million | -3.82 Million | -4.38 Million | -17.68 Million | -1.91 Million | -7.8 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -74.67 Million | -32.34 Million | 80.54 Million | 15.95 Million | 12.5 Million | 21.47 Million |
Free Cash Flow | -28.28 Million | -45.33 Million | 78.28 Million | 27.72 Million | 1.4 Million | 51.63 Million |
MDA
RATNAMANI
4623
0IX0
PCAT
2923